Skip to content
Screener

Charles River Laboratories CRL RMS — Intangible asset impairment

Other segment segments

Manufacturing
$108.97M

Similar metrics at other companies

White Mountains Insurance Group logo
WTMAsset Management (Kudu) — Other intangible assets, impairments
$0
Molina Healthcare logo
MOHMedicare — Impairment of intangible assets
$93M
Synaptics logo
SYNAReportable Segment — Intangible asset impairment charge
$3.45M-13.8%
LiveOne, Inc. logo
LVOSlacker — Intangible Impairment
$0-100%
AgEagle Aerial Systems logo
UAVSSensors — Intangible Impairment
$325K
Comstock Inc. logo
LODEMetals — Intangible Impairment
$2.16M

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$12.56B+70.1%
Enterprise value$15.36B+53.4%
P/S3.1×+1.3×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-6%
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfIntangibleAssetsFinitelived.

The source filing: Charles River Laboratories’s 10-K, filed February 18, 2026.

Filed
Feb 18, 2026, 9:21 AM EST
Fiscal year
FY2025
Accession
0001100682-26-000022
Line itemFiscal Year / December 27, 2025Fiscal Year / December 28, 2024Fiscal Year / December 30, 2023
Cost of revenue (excluding amortization of intangible assets)576,250580,491509,970
Selling, general and administrative101,529110,982105,965
Amortization of intangible assets21,73623,49321,742
Intangible asset impairment102,000
Operating income$44,567$114,411$154,666
DSA
Revenue$2,402,891$2,451,280$2,615,623
Cost of revenue (excluding amortization of intangible assets)1,686,0171,697,1661,675,472

Item 8. Financial Statements and Supplementary Data

FAQ

What is Charles River Laboratories's RMS — intangible asset impairment?
Charles River Laboratories (CRL) reported RMS — intangible asset impairment of $52.75M in Q4 2025.
What does RMS — intangible asset impairment mean?
This metric reflects the non-cash charge recognized when the carrying value of intangible assets within the Research Models and Services segment exceeds their fair value. It indicates a reduction in the expected future economic benefits of acquired assets like patents, customer relationships, or technology.

Ask your AI about Charles River Laboratories's rms — intangible asset impairment.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude